First Trust Advisors LP Lowers Stock Position in USA Compression Partners LP (NYSE:USAC)

First Trust Advisors LP lessened its holdings in shares of USA Compression Partners LP (NYSE:USAC - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 205,022 shares of the oil and gas company's stock after selling 14,236 shares during the period. First Trust Advisors LP owned 0.18% of USA Compression Partners worth $4,830,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Brown Brothers Harriman & Co. bought a new stake in USA Compression Partners during the fourth quarter worth about $95,000. Broadway Wealth Solutions Inc. bought a new stake in shares of USA Compression Partners in the 4th quarter worth approximately $201,000. TSA Wealth Managment LLC purchased a new stake in shares of USA Compression Partners in the 4th quarter worth approximately $205,000. SVB Wealth LLC bought a new position in USA Compression Partners during the 4th quarter valued at approximately $207,000. Finally, Bravias Capital Group LLC purchased a new position in USA Compression Partners during the fourth quarter valued at $230,000. 47.77% of the stock is owned by hedge funds and other institutional investors.

USA Compression Partners Stock Performance

Shares of NYSE USAC traded up $0.52 during midday trading on Friday, hitting $24.94. 63,000 shares of the stock traded hands, compared to its average volume of 349,017. The firm has a market capitalization of $2.93 billion, a P/E ratio of 34.16 and a beta of 0.84. USA Compression Partners LP has a one year low of $21.06 and a one year high of $30.10. The firm has a 50-day moving average of $25.55 and a two-hundred day moving average of $24.76.

USA Compression Partners (NYSE:USAC - Get Free Report) last announced its earnings results on Tuesday, February 11th. The oil and gas company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.06). USA Compression Partners had a negative return on equity of 62.46% and a net margin of 10.48%. Equities analysts forecast that USA Compression Partners LP will post 1.05 earnings per share for the current fiscal year.

USA Compression Partners Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Monday, April 28th will be given a $0.525 dividend. The ex-dividend date of this dividend is Monday, April 28th. This is an increase from USA Compression Partners's previous quarterly dividend of $0.51. This represents a $2.10 annualized dividend and a yield of 8.42%. USA Compression Partners's dividend payout ratio (DPR) is presently 287.67%.

Analyst Ratings Changes

USAC has been the subject of several analyst reports. JPMorgan Chase & Co. raised their price target on USA Compression Partners from $23.00 to $24.00 and gave the company an "underweight" rating in a report on Tuesday, March 11th. Mizuho lifted their target price on shares of USA Compression Partners from $24.00 to $26.00 and gave the stock a "neutral" rating in a report on Monday, February 3rd. Finally, Citigroup increased their price target on shares of USA Compression Partners from $24.00 to $27.00 and gave the company a "neutral" rating in a report on Tuesday, February 25th. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $26.00.

About USA Compression Partners

USA Compression Partners, LP provides compression services under term contracts with customers in the natural gas and crude oil industries in the United States. The company engineers, designs, operates, services, and repairs its compression units; and maintains related support inventory and equipment.